Genmab A/S (CPH:GMAB)
1,419.50
-1.00 (-0.07%)
Jul 18, 2025, 4:59 PM CET
Genmab Revenue
Genmab had revenue of $715.00M USD in the quarter ending March 31, 2025, with 18.57% growth. This brings the company's revenue in the last twelve months to $3.23B, up 25.43% year-over-year. In the year 2024, Genmab had annual revenue of $2.99B with 22.32% growth.
Revenue (ttm)
$3.23B
Revenue Growth
+25.43%
P/S Ratio
3.92
Revenue / Employee
$1.20M
Employees
2,682
Market Cap
87.30B DKK
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.99B | 545.24M | 22.32% |
Dec 31, 2023 | 2.44B | 358.99M | 17.23% |
Dec 31, 2022 | 2.08B | 796.62M | 61.88% |
Dec 31, 2021 | 1.29B | -374.23M | -22.52% |
Dec 31, 2020 | 1.66B | 855.79M | 106.20% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 303.14B |
Coloplast | 27.79B |
Demant | 22.42B |
ALK-Abelló | 5.71B |
H. Lundbeck | 22.95B |
Ambu A/S | 5.83B |
Zealand Pharma | 55.69M |
GN Store Nord | 17.67B |
Genmab News
- 3 days ago - Genmab reports Q2 Darzalex net sales of $3.54 billion - Seeking Alpha
- 3 days ago - Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2025 - GlobeNewsWire
- 17 days ago - Genmab Announces Changes to its Executive Committee - GlobeNewsWire
- 18 days ago - Completion of Share Buy-back Program - GlobeNewsWire
- 25 days ago - Genmab: This Is Anything But A Value Trap, Yet It Is Currently Priced As One - Seeking Alpha
- 25 days ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 4 weeks ago - Capital Increase in Genmab as a Result of Employee Warrant Exercise - GlobeNewsWire
- 4 weeks ago - Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons - GlobeNewsWire